Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-207"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-207"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-9532
lpv:speaker	lp:Jean-Luc Mélenchon2
lpv:spokenAs	vice-chair; AFET (2009-07-16--2011-10-04)3 unknown; Front de gauche pour changer d’Europe (2009-07-14--2014-06-30)3 substitute; CULT (2009-07-16--2012-01-18)3 substitute; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (2009-09-16--2014-06-30)3 member; Delegation for relations with the Mercosur countries (2009-09-16--2014-06-30)3 member; EUL/NGL (2009-07-14--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"This report consists of a reminder of what the European Medicines Agency should be. One cannot oppose a draft that states obvious facts such as the need to ‘place emphasis on the rights and interests of patients’, the need to oblige companies to publicly list the adverse reactions of their medicines and the need to publish information in all the official languages of the European Union. One can, however, be taken aback by the fact that such commonplaces have to be pointed out 15 years after that Agency was created. Parliament should denounce the Agency’s lack of transparency and say loud and clear that it should be reformed in everyone’s interests."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph